Cash flow Zoetis Inc.

Equities

ZTS

US98978V1035

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 03:51:50 2026-01-20 pm EST			5-day change	1st Jan Change
123.30 ^USD	-1.08%		-0.67%	-1.61%

Jan. 12	Zoetis CEO on Animal Health, Vaccines and Beef Prices	MT
Jan. 12	Zoetis Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 10:30 AM

7dd440ac00df9dac7b4d1dd13149aaa.Xv4kr-W_03dZUYiuzHMSRVBR11Nv3pZNlvyYreFfWgo.P5FPxorWnw03Nb-WuUJZczQFmzYdt_gHoJKu5tcTND4HjXHDjO2mFm0p7w

Published financial data: ZOETIS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	6.68B	7.78B	8.08B	8.54B	9.26B
Total Revenues	6.68B	7.78B	8.08B	8.54B	9.26B
Cost of Goods Sold, Total	2.04B	2.3B	2.45B	2.56B	2.72B
Gross Profit	4.64B	5.48B	5.63B	5.99B	6.54B
Selling General & Admin Expenses, Total	1.71B	2B	2.01B	2.15B	2.32B
R&D Expenses	463M	508M	539M	614M	686M
Amortization of Goodwill and Intangible Assets - (IS)	160M	161M	150M	149M	141M
Other Operating Expenses, Total	2.34B	2.67B	2.7B	2.91B	3.14B
Operating Income	2.3B	2.81B	2.94B	3.07B	3.39B
Interest Expense, Total	-231M	-224M	-221M	-239M	-225M
Interest And Investment Income	12M	6M	50M	105M	106M
Net Interest Expenses	-219M	-218M	-171M	-134M	-119M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-21M	-27M	-62M	-47M	-50M
Other Non Operating Income (Expenses)	7M	6M	18M	36M	1M
EBT, Excl. Unusual Items	2.07B	2.57B	2.72B	2.93B	3.22B
Restructuring Charges	-1M	-45M	-15M	-55M	-36M
Merger & Related Restructuring Charges	-25M	-	-	-	-1M
Gain (Loss) On Sale Of Investments	-4M	-	-	-	-
Gain (Loss) On Sale Of Assets	1M	-3M	-	101M	-39M
Asset Writedown	-30M	-30M	-46M	-36M	-15M
Insurance Settlements	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-13M	-6M	-4M	-1M	-1M
EBT, Incl. Unusual Items	2B	2.49B	2.66B	2.94B	3.13B
Income Tax Expense	360M	454M	545M	596M	637M
Earnings From Continuing Operations	1.64B	2.03B	2.11B	2.34B	2.5B
Net Income to Company	1.64B	2.03B	2.11B	2.34B	2.5B
Minority Interest	2M	3M	3M	4M	-10M
Net Income - (IS)	1.64B	2.04B	2.11B	2.34B	2.49B
Net Income to Common Incl Extra Items	1.64B	2.04B	2.11B	2.34B	2.49B
Net Income to Common Excl. Extra Items	1.64B	2.04B	2.11B	2.34B	2.49B
Per Share Items
Net EPS - Basic	3.44	4.29	4.51	5.08	5.47
Basic EPS - Continuing Operations	3.44	4.29	4.51	5.08	5.47
Basic Weighted Average Shares Outstanding	476M	474M	469M	461M	454M
Net EPS - Diluted	3.42	4.27	4.49	5.07	5.47
Diluted EPS - Continuing Operations	3.42	4.27	4.49	5.07	5.47
Diluted Weighted Average Shares Outstanding	479M	477M	470M	462M	455M
Normalized Basic EPS	2.72	3.4	3.63	3.98	4.42
Normalized Diluted EPS	2.7	3.38	3.62	3.97	4.41
Dividend Per Share	0.8	1	1.3	1.5	1.73
Payout Ratio	23.2	23.27	28.9	29.52	31.62
American Depositary Receipts Ratio (ADR)	0.06	0.06	0.06	0.06	0.06
Supplemental Items
EBITDA	2.7B	3.21B	3.33B	3.49B	3.83B
EBITA	2.53B	3.02B	3.13B	3.26B	3.56B
EBIT	2.3B	2.81B	2.94B	3.07B	3.39B
EBITDAR	2.77B	3.28B	3.41B	3.58B	3.92B
Effective Tax Rate - (Ratio)	18.04	18.25	20.52	20.3	20.33
Current Domestic Taxes	268M	346M	595M	376M	710M
Current Foreign Taxes	154M	188M	235M	281M	265M
Total Current Taxes	422M	534M	830M	657M	975M
Deferred Domestic Taxes	-43M	-94M	-247M	-15M	-339M
Deferred Foreign Taxes	-19M	14M	-38M	-46M	1M
Total Deferred Taxes	-62M	-80M	-285M	-61M	-338M
Normalized Net Income	1.29B	1.61B	1.7B	1.83B	2.01B
Interest Capitalized	17M	20M	21M	27M	39M
Interest on Long-Term Debt	248M	244M	242M	266M	264M
Non-Cash Pension Expense	6M	6M	6M	1M	2M
Supplemental Operating Expense Items
Advertising Expense	233M	292M	287M	281M	302M
Selling and Marketing Expenses	233M	292M	287M	281M	302M
Research And Development Expense From Footnotes	463M	508M	539M	614M	686M
Net Rental Expense, Total	73M	78M	75M	87M	90M
Imputed Operating Lease Interest Expense	20.56M	21.4M	19.42M	24.68M	27.82M
Imputed Operating Lease Depreciation	52.44M	56.6M	55.58M	62.32M	62.18M
Stock-Based Comp., Other (Total)	58M	-	62M	60M	74M
Total Stock-Based Compensation	58M	-	62M	60M	74M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	3.6B	3.48B	3.58B	2.04B	1.99B
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	2M	12M	-	-	-
Total Cash And Short Term Investments	3.61B	3.5B	3.58B	2.04B	1.99B
Accounts Receivable, Total	1.01B	1.13B	1.22B	1.3B	1.32B
Total Receivables	1.01B	1.13B	1.22B	1.3B	1.32B
Inventory	1.63B	1.92B	2.34B	2.56B	2.31B
Other Current Assets, Total	364M	377M	365M	434M	377M
Total Current Assets	6.61B	6.93B	7.51B	6.34B	5.99B
Gross Property Plant And Equipment	4.35B	4.68B	5.27B	6.04B	6.25B
Accumulated Depreciation	-1.95B	-2.07B	-2.3B	-2.59B	-2.64B
Net Property Plant And Equipment	2.39B	2.6B	2.97B	3.44B	3.62B
Long-term Investments	22M	33M	10M	12M	26M
Goodwill	2.69B	2.68B	2.75B	2.76B	2.72B
Other Intangibles, Total	1.71B	1.47B	1.38B	1.34B	1.13B
Deferred Tax Assets Long-Term	94M	100M	173M	206M	540M
Other Long-Term Assets, Total	84M	78M	137M	185M	215M
Total Assets	13.61B	13.9B	14.92B	14.29B	14.24B
Liabilities
Accounts Payable, Total	457M	436M	405M	411M	433M
Accrued Expenses, Total	845M	1.09B	977M	1.04B	1.16B
Short-term Borrowings	4M	-	2M	3M	-
Current Portion of Long-Term Debt	621M	3M	1.35B	-	1.35B
Current Portion of Leases	40M	41M	43M	49M	52M
Current Income Taxes Payable	46M	38M	157M	110M	93M
Unearned Revenue Current, Total	13M	6M	5M	-	-
Other Current Liabilities	144M	185M	228M	277M	323M
Total Current Liabilities	2.17B	1.8B	3.17B	1.89B	3.41B
Long-Term Debt	6.61B	6.6B	6.58B	6.59B	5.25B
Long-Term Leases	163M	151M	186M	196M	181M
Unearned Revenue Non Current	-	6M	9M	-	-
Pension & Other Post Retirement Benefits	79M	67M	44M	43M	42M
Deferred Tax Liability Non Current	378M	320M	142M	146M	167M
Other Non Current Liabilities	434M	418M	390M	431M	419M
Total Liabilities	9.84B	9.36B	10.52B	9.3B	9.47B
Common Stock, Total	5M	5M	5M	5M	5M
Additional Paid In Capital	1.06B	1.07B	1.09B	1.13B	1.18B
Retained Earnings	5.66B	7.19B	8.67B	10.3B	11.97B
Treasury Stock	-2.23B	-2.95B	-4.54B	-5.6B	-7.44B
Comprehensive Income and Other	-730M	-764M	-817M	-839M	-940M
Total Common Equity	3.77B	4.54B	4.4B	5B	4.77B
Minority Interest	4M	1M	-2M	-6M	-
Total Equity	3.77B	4.54B	4.4B	4.99B	4.77B
Total Liabilities And Equity	13.61B	13.9B	14.92B	14.29B	14.24B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	475M	472M	463M	458M	448M
ECS Total Common Shares Outstanding	475M	473M	464M	458M	448M
Book Value / Share	7.93	9.61	9.5	10.9	10.64
Tangible Book Value	-635M	387M	279M	900M	919M
Tangible Book Value Per Share	-1.34	0.82	0.6	1.96	2.05
Total Debt	7.44B	6.79B	8.16B	6.84B	6.83B
Net Debt	3.83B	3.3B	4.58B	4.8B	4.84B
Debt Equivalent of Unfunded Proj. Benefit Obligation	79M	67M	44M	43M	42M
Debt Equivalent Oper. Leases	584M	624M	600M	696M	720M
Minority Interest, Total (Incl. Fin. Div)	4M	1M	-2M	-6M	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	229M	339M	430M	451M	377M
Inventories - Work In Process, Total	594M	696M	825M	966M	933M
Inventories - Finished Goods, Total	805M	888M	1.09B	1.15B	996M
Land - (BS)	22M	22M	26M	25M	28M
Buildings, Total	1.02B	1.1B	1.2B	1.32B	1.29B
Machinery, Total	2.44B	2.63B	3.01B	3.37B	3.35B
Full Time Employees	11.3K	12.1K	13.8K	14.1K	13.8K
Accumulated Allowance for Doubtful Accounts (Supple)	20M	17M	19M	18M	18M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.64B	2.04B	2.11B	2.34B	2.49B
Depreciation & Amortization - CF	165M	192M	203M	231M	266M
Amortization of Goodwill and Intangible Assets - (CF)	230M	204M	193M	185M	170M
Depreciation & Amortization, Total	395M	396M	396M	416M	436M
Amortization of Deferred Charges, Total - (CF)	46M	52M	69M	75M	61M
(Gain) Loss From Sale Of Asset	-19M	2M	-	-118M	23M
Asset Writedown & Restructuring Costs	43M	47M	53M	46M	31M
Stock-Based Compensation (CF)	59M	58M	62M	60M	74M
Other Operating Activities, Total	49M	-36M	-83M	42M	-237M
Change In Accounts Receivable	74M	-155M	-137M	-102M	-61M
Change In Inventories	-346M	-366M	-486M	-361M	-40M
Change In Accounts Payable	147M	-17M	-29M	13M	31M
Change in Other Net Operating Assets	40M	195M	-47M	-62M	149M
Cash from Operations	2.13B	2.21B	1.91B	2.35B	2.95B
Capital Expenditure	-453M	-477M	-586M	-732M	-655M
Sale of Property, Plant, and Equipment	21M	2M	1M	4M	1M
Cash Acquisitions	-113M	-14M	-312M	-155M	-8M
Divestitures	-	-	-	96M	293M
Investment in Marketable and Equity Securities, Total	-	-12M	-9M	-4M	-5M
Other Investing Activities, Total	-27M	43M	23M	14M	59M
Cash from Investing	-572M	-458M	-883M	-777M	-315M
Short Term Debt Issued, Total	4M	-	2M	1M	-
Long-Term Debt Issued, Total	1.24B	-	1.35B	-	-
Total Debt Issued	1.24B	-	1.35B	1M	-
Short Term Debt Repaid, Total	-	-4M	-	-	-3M
Long-Term Debt Repaid, Total	-500M	-600M	-	-1.35B	-
Total Debt Repaid	-500M	-604M	-	-1.35B	-3M
Issuance of Common Stock	20M	-	-	27M	-
Repurchase of Common Stock	-250M	-778M	-1.63B	-1.09B	-1.87B
Common Dividends Paid	-380M	-474M	-611M	-692M	-786M
Common & Preferred Stock Dividends Paid	-380M	-474M	-611M	-692M	-786M
Other Financing Activities, Total	-11M	-6M	-11M	-3M	-5M
Cash from Financing	123M	-1.86B	-904M	-3.11B	-2.66B
Foreign Exchange Rate Adjustments	-7M	-12M	-29M	-7M	-32M
Net Change in Cash	1.67B	-119M	96M	-1.54B	-54M
Supplemental Items
Cash Interest Paid	257M	253M	242M	295M	274M
Cash Income Tax Paid (Refund)	418M	548M	638M	754M	892M
Levered Free Cash Flow	1.38B	1.41B	1.17B	1.28B	2.37B
Unlevered Free Cash Flow	1.53B	1.55B	1.31B	1.43B	2.51B
Change In Net Working Capital	-42M	180M	464M	312M	-476M
Net Debt Issued / Repaid	744M	-604M	1.35B	-1.35B	-3M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	11.43	12.77	12.73	13.15	14.87
Return on Total Capital	13.98	15.58	15.36	15.74	18.1
Return On Equity %	50.49	48.91	47.19	49.82	51.14
Return on Common Equity	50.58	49.01	47.25	49.86	50.91
Margin Analysis
Gross Profit Margin %	69.47	70.49	69.73	70.06	70.64
SG&A Margin	25.66	25.73	24.86	25.18	25.04
EBITDA Margin %	40.39	41.24	41.24	40.82	41.37
EBITA Margin %	37.92	38.77	38.73	38.12	38.49
EBIT Margin %	34.47	36.15	36.34	35.96	36.66
Income From Continuing Operations Margin %	24.51	26.16	26.13	27.39	26.97
Net Income Margin %	24.54	26.2	26.16	27.43	26.86
Net Avail. For Common Margin %	24.54	26.2	26.16	27.43	26.86
Normalized Net Income Margin	19.39	20.71	21.08	21.46	21.67
Levered Free Cash Flow Margin	20.7	18.11	14.53	14.95	25.63
Unlevered Free Cash Flow Margin	22.86	19.91	16.24	16.7	27.15
Asset Turnover
Asset Turnover	0.53	0.57	0.56	0.58	0.65
Fixed Assets Turnover	2.95	3.11	2.9	2.66	2.62
Receivables Turnover (Average Receivables)	6.36	7.25	6.88	6.78	7.07
Inventory Turnover (Average Inventory)	1.34	1.29	1.15	1.04	1.12
Short Term Liquidity
Current Ratio	3.05	3.86	2.37	3.36	1.75
Quick Ratio	2.13	2.58	1.51	1.77	0.97
Operating Cash Flow to Current Liabilities	0.98	1.23	0.6	1.25	0.87
Days Sales Outstanding (Average Receivables)	57.55	50.37	53.03	53.81	51.8
Days Outstanding Inventory (Average Inventory)	272.79	282.38	318.44	350.23	327.89
Average Days Payable Outstanding	61.49	62.92	53.52	53.63	62.79
Cash Conversion Cycle (Average Days)	268.85	269.82	317.96	350.41	316.91
Long Term Solvency
Total Debt/Equity	197.19	149.47	185.44	137.01	143.17
Total Debt / Total Capital	66.35	59.92	64.97	57.81	58.88
LT Debt/Equity	179.57	148.5	153.76	135.96	113.77
Long-Term Debt / Total Capital	60.42	59.53	53.87	57.37	46.79
Total Liabilities / Total Assets	72.28	67.31	70.5	65.06	66.5
EBIT / Interest Expense	9.96	12.55	13.29	12.85	15.08
EBITDA / Interest Expense	11.99	14.67	15.42	14.96	17.42
(EBITDA - Capex) / Interest Expense	10.03	12.54	12.76	11.9	14.51
Total Debt / EBITDA	2.69	2.07	2.4	1.91	1.74
Net Debt / EBITDA	1.38	1	1.35	1.34	1.24
Total Debt / (EBITDA - Capex)	3.21	2.42	2.89	2.41	2.09
Net Debt / (EBITDA - Capex)	1.66	1.17	1.62	1.69	1.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6.63	16.49	3.91	5.74	8.33
Gross Profit, 1 Yr. Growth %	6.72	18.2	2.79	6.25	9.22
EBITDA, 1 Yr. Growth %	8.62	18.95	3.9	4.68	9.78
EBITA, 1 Yr. Growth %	8.44	19.12	3.78	4.09	9.4
EBIT, 1 Yr. Growth %	9.73	22.16	4.45	4.63	10.45
Earnings From Cont. Operations, 1 Yr. Growth %	9.07	24.33	3.79	10.85	6.67
Net Income, 1 Yr. Growth %	9.2	24.36	3.78	10.88	6.06
Normalized Net Income, 1 Yr. Growth %	8.38	24.41	5.78	7.62	9.4
Diluted EPS Before Extra, 1 Yr. Growth %	9.97	24.85	5.15	12.92	7.89
Accounts Receivable, 1 Yr. Growth %	-6.72	11.85	7.24	7.33	0.92
Inventory, 1 Yr. Growth %	15.46	18.12	21.94	9.34	-10.06
Net Property, Plant and Equip., 1 Yr. Growth %	12.45	8.73	14.21	15.81	5.11
Total Assets, 1 Yr. Growth %	17.88	2.14	7.37	-4.28	-0.34
Tangible Book Value, 1 Yr. Growth %	-64.21	-160.94	-27.91	222.58	2.11
Common Equity, 1 Yr. Growth %	39.18	20.54	-3.04	13.44	-4.54
Cash From Operations, 1 Yr. Growth %	18.44	4.09	-13.6	23.06	25.5
Capital Expenditures, 1 Yr. Growth %	-1.52	5.3	22.85	24.91	-10.52
Levered Free Cash Flow, 1 Yr. Growth %	22.47	6.36	-19.43	8.84	85.66
Unlevered Free Cash Flow, 1 Yr. Growth %	20.39	5.43	-17.84	8.77	76.08
Dividend Per Share, 1 Yr. Growth %	21.95	25	30	15.38	15.2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.05	11.45	10.02	4.82	7.03
Gross Profit, 2 Yr. CAGR %	8.73	12.31	10.23	4.51	7.72
EBITDA, 2 Yr. CAGR %	11.31	13.67	11.17	4.29	7.2
EBITA, 2 Yr. CAGR %	11.17	13.66	11.19	3.94	6.71
EBIT, 2 Yr. CAGR %	10.31	15.78	12.96	4.54	7.5
Earnings From Cont. Operations, 2 Yr. CAGR %	7.19	16.45	13.59	7.26	8.74
Net Income, 2 Yr. CAGR %	7.1	16.53	13.6	7.27	8.44
Normalized Net Income, 2 Yr. CAGR %	9.85	16.12	14.72	6.7	8.5
Diluted EPS Before Extra, 2 Yr. CAGR %	8.04	17.17	14.58	8.97	10.37
Accounts Receivable, 2 Yr. CAGR %	-1.12	2.14	9.52	7.28	4.07
Inventory, 2 Yr. CAGR %	8.18	16.78	20.02	15.47	-0.84
Net Property, Plant and Equip., 2 Yr. CAGR %	20.16	10.57	11.44	15.01	10.33
Total Assets, 2 Yr. CAGR %	12.37	9.73	4.72	1.38	-2.33
Tangible Book Value, 2 Yr. CAGR %	-48.35	-53.29	-33.72	52.5	81.49
Common Equity, 2 Yr. CAGR %	31.34	29.52	8.11	4.88	4.06
Cash From Operations, 2 Yr. CAGR %	8.98	11.03	-5.17	3.11	24.28
Capital Expenditures, 2 Yr. CAGR %	15.77	1.83	13.74	23.88	5.72
Levered Free Cash Flow, 2 Yr. CAGR %	9.47	15.12	-7.86	-6.35	42.15
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.11	13.5	-7.31	-5.47	38.39
Dividend Per Share, 2 Yr. CAGR %	25.99	23.47	27.48	22.47	15.29
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.94	10.11	8.88	8.58	5.98
Gross Profit, 3 Yr. CAGR %	9.35	11.8	9.05	8.88	6.05
EBITDA, 3 Yr. CAGR %	11.08	13.8	10.31	8.96	6.09
EBITA, 3 Yr. CAGR %	11.05	13.76	10.26	8.77	5.72
EBIT, 3 Yr. CAGR %	9.6	14.13	11.87	10.11	6.47
Earnings From Cont. Operations, 3 Yr. CAGR %	23.81	12.62	12.06	12.67	7.06
Net Income, 3 Yr. CAGR %	23.77	12.57	12.12	12.69	6.87
Normalized Net Income, 3 Yr. CAGR %	9.6	14.5	12.57	12.3	7.59
Diluted EPS Before Extra, 3 Yr. CAGR %	25.02	13.38	13.02	14.02	8.61
Accounts Receivable, 3 Yr. CAGR %	0.5	3.03	3.81	8.78	5.12
Inventory, 3 Yr. CAGR %	4.49	11.4	18.48	16.35	6.24
Net Property, Plant and Equip., 3 Yr. CAGR %	18.6	16.22	11.77	12.88	11.61
Total Assets, 3 Yr. CAGR %	16.59	8.85	8.94	1.63	0.8
Tangible Book Value, 3 Yr. CAGR %	-14.3	-45.42	-46.02	12.33	33.41
Common Equity, 3 Yr. CAGR %	28.65	27.63	17.61	9.86	1.64
Cash From Operations, 3 Yr. CAGR %	16.46	7.33	2.13	3.44	10.09
Capital Expenditures, 3 Yr. CAGR %	26.46	12.17	8.4	17.35	11.15
Levered Free Cash Flow, 3 Yr. CAGR %	10.93	6.88	3.39	-2.6	17.64
Unlevered Free Cash Flow, 3 Yr. CAGR %	10.81	6.49	2.97	-2.24	16.31
Dividend Per Share, 3 Yr. CAGR %	23.96	25.66	25.61	23.31	20
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.97	9.73	8.77	7.96	8.14
Gross Profit, 5 Yr. CAGR %	8.5	11.08	9.7	8.82	8.52
EBITDA, 5 Yr. CAGR %	13.13	13.58	11.12	9.9	9.06
EBITA, 5 Yr. CAGR %	13.85	14.1	11.11	9.72	8.83
EBIT, 5 Yr. CAGR %	12.82	13.94	10.93	10.19	10.1
Earnings From Cont. Operations, 5 Yr. CAGR %	37	19.95	19.62	10.44	10.72
Net Income, 5 Yr. CAGR %	37.03	19.93	19.6	10.42	10.63
Normalized Net Income, 5 Yr. CAGR %	12.57	14.8	11.62	11.31	10.92
Diluted EPS Before Extra, 5 Yr. CAGR %	38.2	20.95	20.74	11.59	11.96
Accounts Receivable, 5 Yr. CAGR %	1.57	4.41	4.01	4.71	3.92
Inventory, 5 Yr. CAGR %	2.1	5.07	10.44	13.01	10.34
Net Property, Plant and Equip., 5 Yr. CAGR %	12.87	13.52	15.68	15.74	11.19
Total Assets, 5 Yr. CAGR %	11.45	12.69	11.69	5.8	4.28
Tangible Book Value, 5 Yr. CAGR %	-16.63	-20.54	-22.67	-17.67	-12.33
Common Equity, 5 Yr. CAGR %	28.69	25.03	20	17.99	11.99
Cash From Operations, 5 Yr. CAGR %	26.21	25.42	7.27	5.62	10.47
Capital Expenditures, 5 Yr. CAGR %	15.13	17.17	21.21	16.71	7.32
Levered Free Cash Flow, 5 Yr. CAGR %	8.3	17.25	3.01	2.07	17.43
Unlevered Free Cash Flow, 5 Yr. CAGR %	8.72	15.94	3.19	2.17	15.9
Dividend Per Share, 5 Yr. CAGR %	19.23	21.35	25.35	24.37	21.37